Comparison of remimazolam and midazolam administration in ketamin infusion therapy for chronic pain patients
Not Applicable
Completed
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0008955
- Lead Sponsor
- Konkuk University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
1) a target disease
Chronic pain diseases subject to sedative treatment using ketamine, such as complex regional pain syndrome, fiber muscle pain, and neuropathic pain.
2) Selection criteria and exclusion criteria of study subjects
- Patients who are being treated for chronic pain for more than 6 months
- Patients with neuropathic pain or fibromyalgia
- Patients who agree with the study process
Exclusion Criteria
- Patients who are hypersensitive or allergic to ketamine, remimazolam, and midazolam
- Drugs or alcoholics
- Patients with heart disease such as angina, arrhythmia, and heart failure
- Pregnant or potentially pregnant patients
- Patients who disagree with the study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain severity
- Secondary Outcome Measures
Name Time Method side effects